NCT06268327 2024-02-20
Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy
Assiut University
Phase 2/3 Not yet recruiting
Clinical Trials
4 trialsNCT02641847 2024-01-25
TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature
Fudan University
Phase 2/3 Active not recruiting
NCT02221999 2023-08-29
SHPD002
RenJi Hospital
Phase 2/3 Active not recruiting
NCT03423849 2018-02-06
The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy
Shandong Cancer Hospital and Institute
Phase 2/3 Unknown